The future of RIP2/RICK/CARDIAK as a biomarker of the inflammatory response to infection.

Citation data:

Expert review of molecular diagnostics, ISSN: 1744-8352, Vol: 8, Issue: 3, Page: 257-61

Publication Year:
2008
Usage 57
Abstract Views 57
Captures 6
Readers 5
Exports-Saves 1
Citations 5
Citation Indexes 5
Repository URL:
https://ir.lib.uwo.ca/immunologypub/5
PMID:
18598105
DOI:
10.1586/14737159.8.3.257
Author(s):
McCully, Michelle L.; Fairhead, Todd; Blake, Peter G.; Madrenas, Joaquin
Publisher(s):
Informa UK Limited
Tags:
Medicine; Biochemistry, Genetics and Molecular Biology; Biological Markers; Humans; Infection; Inflammation; Peritoneal Dialysis; Peritonitis; Receptor-Interacting Protein Serine-Threonine Kinase 2; Immunology and Infectious Disease
review description
Biological markers of disease have become increasingly important for the clinician to diagnose, predict and monitor progression, and assess the therapeutic effect of interventions on underlying pathogenic mechanisms. Robust and specific biomarkers would be very useful in inflammation, where they may facilitate early identification of tissue injury, predict disease progression and help to modify disease outcomes. However, at present, there are no robust biomarkers to predict the course of inflammation. Here, we discuss emerging data indicating that RIP2, a putative serine/threonine protein kinase, may serve as a biomarker for the resolution of peritoneal dialysis-associated peritonitis and, more generally, of the acute inflammatory response to infection.